The following table is a summary of stock option and SAR activity for the years ended December 31, 2025, 2024 and 2023.
the grant date. Stock options granted through 2018 generally expire seven years after the grant date. Stock options and SARs The dividend yield is based on annual dividends paid and the fair market value of CVS Health Corporation stock at the grant date. life of each option grant after adjustments for infrequent events such as stock splits. (3) The risk-free interest rate is selected based on yields from U.S. Treasury zero-coupon issues with a remaining term equal to the expected term of the As of December 31, 2025, unrecognized compensation expense related to unvested stock options and SARs totaled $28 million, which the Company expects to be recognized over a weighted-average period of 1.8 years. After considering anticipated forfeitures, the Company expects approximately 4 million of the unvested stock options and SARs to vest over the requisite In thousands, except weighted average exercise price and remaining the ESPP, eligible employees may purchase common stock at the end of each six-month offering period at a purchase price equal to 90% of the lower of the fair market value on the first day or the last day of the offering period. During 2025,